MediPharm Labs Corp.
MEDIF
$0.061
$0.00010.16%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 19.75% | -5.03% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 19.75% | -5.03% | |||
| Cost of Revenue | 20.94% | -3.13% | |||
| Gross Profit | 17.31% | -8.68% | |||
| SG&A Expenses | -22.75% | -6.64% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -160.35% | 389.58% | |||
| Total Operating Expenses | -2.14% | -2.78% | |||
| Operating Income | 85.37% | -6.84% | |||
| Income Before Tax | 39.37% | -7.74% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 39.37% | -7.74% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 39.37% | -7.74% | |||
| EBIT | 85.37% | -6.84% | |||
| EBITDA | 107.48% | -21.16% | |||
| EPS Basic | 38.78% | -4.26% | |||
| Normalized Basic EPS | 93.33% | -11.11% | |||
| EPS Diluted | 38.78% | -4.26% | |||
| Normalized Diluted EPS | 93.33% | -11.11% | |||
| Average Basic Shares Outstanding | 0.18% | 1.55% | |||
| Average Diluted Shares Outstanding | 0.18% | 1.55% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||